JPRN-UMIN000023990已完成未知
Efficacy study of oral Ginkgo biloba extract to improve brain function for the middle aged and elderly - Efficacy study of oral Ginkgo biloba extract to improve brain function
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- Itty, INC.
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45years-old 至 69years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects who are difficult to discriminate color 2) Subjects with bad eyesight, or are diagnosed with amblyopia or blindness 3) Subjects with bad hearing, or are diagnosed with hearing loss or permanent hearing loss 4) Subjects who get a score of 20 or less on the Revised HDS-R 5) Subjects with history of cranial nerve disease 6) Subjects who have depressive symptoms, or who have been diagnosed as depressive disorder 7) Subjects who are under hormone treatment or are diagnosed with menopause 8) Subjects who have some irregular schedules during the study, due to night work or something 9) Subjects who drink much alcohol 10) Subjects who smoke, or quit smoking within one year before pre-inspection 11) Subjects who have done the same brain function test before 12) Subjects who are under treatment of brain functions, or are prescribed with medicine for them 13) Subjects who continuously take medicine, health foods, Food for Specified Health Uses or Foods with Function Claims including substance related to brain functions 14) Subjects who was given or donated 200 ml or 400 ml whole blood within three months before pre-inspection 15) Subjects who participated in other study within one month before pre-inspection, or are going to participate in other study during the study 16) Subjects who have a disease which needs regular medication, or have a history of the disease 17) Subjects who are judged as unsuitable for the study by investigator because of clinical test, anthropometric test and physical examination in pre-inspection 18) Subjects who are in danger of allergy to the study 19) Subjects who are taking warfarin in the brain infarction or heart or need to take warfarin during the study 20) Subjects who are pregnant or lactating, or plan to become pregnant or lactate during the study 21) Subjects who are judged as unsuitable for the study because of lifestyle questionnaire 22) Subjects who are judged as unsuitable for the study by investigator for other reasons
研究者
相似试验
已完成
不适用
Association of the simultaneous administration of Gingko biloba extract and absorption promoting agent with cognitive functioHealthy adultsJPRN-UMIN000043494Department of Aging Research and Geriatric Medicine IDAC, Tohoku University155
尚未招募
4 期
The effectiveness of Ginkgo biloba extract EGB 761 in tinnitus: a randomized-controlled trialsubjective tinnitus for 4 weeks to 1 yearGinkgo bilobatinnitus handicap inventoryHADStinnitusTCTR20221228003Ratchadaphiseksomphot Endowment Fund46
招募中
3 期
Effect of Ginkgo Biloba extract in comparison with placebo on prevention of tinnitus and ototoxicity in patients treated with cisplatiPrevention of ototoxicity of cisplatin.Ototoxic hearing lossIRCT2015020720982N1Tehran University of Medical Sciences48
招募中
3 期
Evaluation of the Effectiveness of Ginkgo Biloba regimen on cognitive function in patients undergoing electroconvulsive therapy: Double blind clinical trialPsychosis.Other stimulant related disordersIRCT20200516047470N1Ahvaz University of Medical Sciences80
招募中
2 期
Gingko Biloba efficacy in treatment of drug-induced parkinsonismdrug-induced parkinsonism.Other drug-induced secondary parkinsonismG21.21IRCT20200708048060N1Tehran University of Medical Sciences102